The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Much Larger Will The Genomic Cancer Panel And Profiling Market Become By 2030 Compared To 2026?
The genomic cancer panel and profiling market has experienced substantial expansion in recent times. Its value is expected to rise from $10.28 billion in 2025 to $11.17 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.7%. The market’s previous growth phases are linked to an uptick in cancer prevalence, developments in sequencing technologies, the widening scope of oncology diagnostics, augmented funding for genomic research, and the increasing utilization of precision medicine.
The genomic cancer panel and profiling market is anticipated to experience substantial expansion over the coming years. Its valuation is projected to reach $15.45 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.4%. This projected increase during the forecast period is driven by factors such as the wider application of companion diagnostics, the growing acceptance of liquid biopsy, the incorporation of AI into genomic analysis, the rise in oncology screening initiatives, and the creation of more economical sequencing platforms. Key developments foreseen for this period include the increased uptake of multi-gene cancer panels, the greater utilization of next-generation sequencing, the broadening scope of liquid biopsy testing, the rising need for personalized oncology solutions, and the incorporation of genomic information into clinical decision-making processes.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24225&type=smp
What Important Drivers Are Powering The Genomic Cancer Panel And Profiling Market Growth?
The escalating occurrence of cancer is anticipated to propel the expansion of the genomic cancer panel and profiling market moving forward. Cancer is characterized as a condition involving the uncontrolled proliferation and dissemination of abnormal cells within the body. This increase in cancer incidence is attributed to an aging global population, which elevates the risk of developing cancer as life expectancy continues to rise. Genomic cancer panels and profiling contribute to oncology care by identifying genetic mutations and biomarkers, thereby enabling personalized treatment strategies and enhancing early detection and monitoring. For example, in January 2024, the American Cancer Society, a U.S.-based nonprofit organization, reported that in 2022, approximately 20 million new cancer cases were identified globally, resulting in 9.7 million deaths. Primarily driven by population growth, the global cancer burden is projected to reach 35 million cases by 2050. Consequently, the increasing incidence of cancer will significantly drive the growth of the genomic cancer panel and profiling market.
What Segment Types Are Included In The Genomic Cancer Panel And Profiling Market Analysis?
The genomic cancer panel and profiling market covered in this report is segmented –
1) By Tissue Testing: Solid Tissue Testing, Liquid Tissue Testing
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence In-Situ Hybridization (FISH), Immunohistochemistry (IHC), Other Technologies
3) By Cancer Panel Type: Single-Gene Panel, Multi-Gene Panel
4) By Application: Clinical, Research
5) By End User: Hospitals, Research And Academic Institutes, Clinical And Diagnostic Laboratories, Other End Users
Subsegments:
1) By Solid Tissue Testing: Biopsy Samples, Surgical Resection Samples, Formalin-Fixed Paraffin-Embedded (FFPE) Tissues, Fresh Frozen Tissues
2) By Liquid Tissue Testing: Blood, Urine, Saliva, Cerebrospinal Fluid (CSF), Other Bodily Fluids
Which Trends Are Expected To Shape The Genomic Cancer Panel And Profiling Market?
Major corporations operating in the genomic cancer panel and profiling market are prioritizing technological advancements, such as next-generation sequencers, to boost the accuracy, speed, and overall comprehensiveness of cancer diagnostics, thereby enabling more individualized treatment options. Next-generation sequencers are sophisticated DNA sequencing technologies that facilitate rapid, high-throughput examination of genetic material to pinpoint mutations, variations, and other genomic attributes. For instance, in April 2025, QIAGEN N.V., a Netherlands-based biotechnology firm, introduced QIAseq panels, which are designed for next-generation sequencers and allow for comprehensive genomic profiling by analyzing over 700 genes. These panels are intended for both research and clinical applications, with the goal of enhancing cancer diagnostics and treatment strategies.
Which Firms Are Competing In The Genomic Cancer Panel And Profiling Market?
Major companies operating in the genomic cancer panel and profiling market are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Hologic Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, ARUP Laboratories, Tempus Labs, Genscript Biotech Corporation, NeoGenomics Inc., Foundation Medicine, Invitae Corporation, Guardant Health Inc., Caris Life Sciences, Fulgent Genetics, NanoString Technologies Inc., Genecast Biotechnology Co. Ltd, Burning Rock DX, HTG Molecular Diagnostics Inc., Predictive Oncology Inc.
Access The Complete Genomic Cancer Panel And Profiling Market Report:
Which Region Stands As The Largest Contributor To The Genomic Cancer Panel And Profiling Market?
North America was the largest region in the genomic cancer panel and profiling market in 2025. The regions covered in the genomic cancer panel and profiling market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Genomic Cancer Panel And Profiling Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=24225&type=smp
Browse Through More Reports Similar to the Global Genomic Cancer Panel And Profiling Market 2026, By The Business Research Company
Cancer Profiling Market Report 2026
https://www.thebusinessresearchcompany.com/report/cancer-profiling-global-market-report
Genomics In Cancer Care Market Report 2026
https://www.thebusinessresearchcompany.com/report/genomics-in-cancer-care-global-market-report
Cancer Tumor Profiling Market Report 2026
https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model